Xenazine is a medication intended to decrease the uncontrollable movements caused by Huntington's disease. It contains the main active component Tetrabenazine, which belongs to a class of drugs known as vesicular monoamine transporter type 2 inhibitors. This medicine is made available in a dosage of 25 mg in a conventional tablet form. Genzyme Corporation, the leading pharmaceutical company has been manufacturing this medicine.
Manufacturer: Genzyme Corporation
Active Ingredient: Tetrabenazine is used as an active ingredient in this medication. It is a vesicular monoamine transporter type 2 inhibitor, which are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals. This component is used to treat chorea due to neurodegenerative diseases like Huntington chorea or dyskinesias due to neuroleptic medications.
Indications: Tetrabenazine composed medicine is approved to reduce the uncontrollable movements like chorea caused by Huntington's disease. This drug is not a cure for the disease. Decreasing the chorea will help take part in more of normal daily activities. Xenazine is thought to decrease the amount of certain natural substances in the brain, monoamines such as dopamine, serotonin, and norepinephrine. These are involved with nerve and muscle function. This drug belongs to a class of drugs called monoamine depletors.
Action Mechanism: This mentioned medication belongs to a class of drugs called monoamine depletors. Xenazine reduces the number of certain chemicals in the body that are more active in people with Huntington's disease.
Dosages: This medicine is available in a dosage as mentioned below:
- 25 mg: This tablet must be taken once a day in the morning with or without food as prescribed by the doctor
Note: This medication is not recommended in people who have severe or untreated depression, suicidal thoughts, or liver disease.